Facebook
Twitter
Telegram
Report an ErrorRAPT Therapeutics Financial Statements 2011-2024 | RAPT
Annual Financial Statements RAPT Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
358 M | 640 M | 1.01 B | 487 M | 194 M | - | - | - | - | - | - | - | - |
Shares |
38.3 M | 32.5 M | 27.4 M | 24.4 M | 4.35 M | - | - | - | - | - | - | - | - |
Historical Prices |
9.35 | 19.7 | 36.7 | 19.8 | 27.6 | - | - | - | - | - | - | - | - |
Net Income |
-117 M | -83.8 M | -69.2 M | -52.9 M | -43 M | -36.1 M | -29.1 M | - | - | - | - | - | - |
Revenue |
- | 1.53 M | 3.81 M | 5.04 M | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | 5.04 M | - | - | - | - | - | - | - | - | - |
Operating Income |
-127 M | -85.8 M | -69.2 M | -53.2 M | -43.6 M | -36.9 M | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-126 M | -84.7 M | -68.2 M | -52.7 M | -42.3 M | -35.7 M | -27.9 M | - | - | - | - | - | - |
Operating Expenses |
127 M | 87.3 M | 73 M | 58.3 M | 43.6 M | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
26.1 M | 20.2 M | 16 M | 12.8 M | 8.72 M | 5.18 M | 3.71 M | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement RAPT Therapeutics
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
38.4 M | 38.3 M | 38.3 M | - | 33.7 M | 31.1 M | 29.6 M | 29.6 M | 29.5 M | 25.6 M | 24.8 M | 24.8 M | 24.4 M | 24.3 M | 23.3 M | 21.8 M | 803 K | 719 K | 692 K | 878 K | 647 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-31.4 M | -25.3 M | -29.3 M | - | -21.2 M | -19.2 M | -20.5 M | - | -18.7 M | -16.1 M | -16.5 M | - | -14.6 M | -12.4 M | -13.1 M | - | -9.97 M | -10.6 M | -9.19 M | - | -10.3 M | -8.2 M | -8.23 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | 1.53 M | 886 K | 641 K | - | 966 K | 869 K | 1.22 M | - | 1.53 M | 1.28 M | 935 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-33.9 M | -28.4 M | -31.6 M | - | -21.7 M | -18.9 M | -20.8 M | - | -18.5 M | -16.1 M | -16.6 M | - | -14.6 M | -12.5 M | -13 M | - | -10.3 M | -11 M | -9.54 M | - | -10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-33.6 M | -28.1 M | -31.3 M | - | -21.4 M | -18.7 M | -20.5 M | - | -18.3 M | -15.9 M | -16.3 M | - | -14.3 M | -12.1 M | -12.8 M | - | -10 M | -10.6 M | -9.21 M | - | -10.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
33.9 M | 28.4 M | 31.6 M | - | 21.7 M | 19.8 M | 21.4 M | - | 19.5 M | 17 M | 17.8 M | - | 16.1 M | 13.8 M | 14 M | - | 10.3 M | 11 M | 9.54 M | - | 10.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.9 M | 6.72 M | 5.99 M | - | 5.08 M | 5.44 M | 4.75 M | - | 3.77 M | 3.76 M | 4.01 M | - | 3.2 M | 2.8 M | 3.29 M | - | 1.73 M | 2.69 M | 1.67 M | - | 1.36 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency